NEWS

Dive deeper into the world of compounds and reagents in our news and blog posts.

December 13, 2021
Viruses are pathogens occurring all around us that can be fought with antiviral drugs. Viruses are the cause of a large number of diseases, many of which are deadly – from ...
author foto
Krystof Sigut
December 6, 2021
Over the last few decades, several approaches have been developed to synthesise short DNA sequences.Relevant approaches include the phosphodiester method and the H-phosphonate method. However, higher yields and higher ...
author foto
Krystof Sigut
November 26, 2021
[vc_row][vc_column][vc_column_text] AIDS is a terminal disease caused by the human immunodeficiency virus (HIV), affecting millions worldwide.HIV belongs to the group of retroviruses, which ...
author foto
Krystof Sigut
November 19, 2021
[vc_row][vc_column][vc_column_text] Molnupiravir is a new potential drug against the SARS-CoV-2 infectious virus.   To this date, all medications against SARS-CoV-2 are administered only by infusion ...
author foto
Krystof Sigut
November 3, 2021
Base-modified DNA could potentially find widespread application in medicinal chemistry and therapy, as well as in material science.[1] Examples of applications of base-modified oligonucleotides include aptamers for therapy[2], as scorpion ...
author foto
Krystof Sigut
October 11, 2021
During the course of the last decades, outstanding efforts were devoted to design and develop nucleotide prodrugs to be employed as potential therapeutic agents, especially for the treatment of human ...
author foto
Alessandro Panattoni
Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner

Welcome to
SigutLabs

We have grown from a tiny lab to a reputable partner of global pharmaceutical leaders, scientific institutes, and biotechnology giants. Our team is composed of PhDs experts eager to help you succeed through high-end expertise combined with cost-effective reliability.

More about us
Sigut
welcome to sigutlabs
welcome to sigutlabs